0.0002 SHNM (Pharmaceutical) great news today.
For those of you that missed out on VDRM's (another pharmaceutical company) 2017 meteoric rise to 6 cents - you may have a good shot for the same with SHMN. Even better. SHMN is only trading at $0.0002 and it didn't get its below news today disseminated hardly anywhere. That's a good thing for early investors. Pharmaceutical companies nearly always do very well in the OTC market. There is always a new drug in the news with them.
This seems to be a common occurrence with pink sheet stocks. They think the free OTC markets is all the news dissemination they need. But hardly nobody uses that service. IHUB charges just $100. Toget it into YaHoo Finance, ETRADE and other huge places a company needs to advertise via MarketWired or other outlets.
SEE MORE ABOUT SHMN on TWITTER here:
SOHM Inc., Signs Strategic Alliance with Manufacturing Unit in Southern California To Increase Revenue.
04/28/2017 posted in Press Releases
Partnerships and Alliances To Strengthen Market Penetration and Revenue Growth in Year 2017 and beyond.
Chino Hills, CA — April 27, 2017 – SOHM, Inc. (PINKSHEETS: SHMN), a manufacturer of generic drugs covering all major treatment categories in Pharmaceutical, Nutraceutical and Cosmeceutical drug products announced today that it has signed a strategic alliance with a manufacturing unit in Southern California. This alliance strengthens SOHM’s manufacturing capabilities within the United States for distribution and export to other countries.
The company expects partnerships and alliances to strengthen market penetration and revenue growth in key emerging markets within the United States through its distribution channels. Alliance allows SOHM to double pharmaceutical production capability, reduce costs by several percent, increase profitability and restore its lost revenue from recent years. This alliance will make a positive impact on SOHM’s revenue by the end of Q3.
The strategic alliance with this manufacturing house currently has a range of 90 products covering major therapeutic categories. SOHM will utilize its spare manufacturing capacity of the manufacturing house.
“The manufacturing house facilities can produce all essential products in the dosage forms including tablets, capsules, flavored nutritional powders, sports energy drink powders, oral liquids, ointments, creams with excellent packing facilities, this will allow SOHM, Inc, USA to fulfill its growing market demand in the coming season and achieve the manufacturing volume growth needed to fulfill future purchase orders. This step also align company with current focus of USA to “Manufacturer in USA” by the government of USA and this will help to reduce operating costs and increase profitability.”
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a global presence and marketing plan that assure continuous growth. SOHM manufacturing and marketing target the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing in India. Although SOHM’s generic pharmaceuticals are exported globally and was introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
Forward-Looking Statements
This press release contains many forward-looking statements such as “project,” “plan,” “can,” etc. Such statements are subject to possible uncertain risks that may vary actual results from those intended in or expressed by the forward-looking statements. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
“Too many people are thinking security instead of opportunity. They seem more afraid of life than death.” – James F. Byrnes
